NYSE$ACH
Accendra Health Inc · Q3 2024 earnings
Q3 2024 earnings · · Investor relations
Briefing
Owens & Minor's financial performance in Q3 2024 reflected top-line growth driven by patient direct and medical distribution demand and total debt reduction.
Owens & Minor reported a 5% increase in consolidated revenue, reaching $2.7 billion. The company experienced a GAAP net loss of $(13) million, but achieved an adjusted EPS of $0.42. Adjusted EBITDA grew by 5% to $142 million, and total debt was reduced by $198 million.
- Consolidated revenue increased by 5% year-over-year, reaching $2.7 billion.
- GAAP Net loss was $(13) million, with adjusted earnings per share at $0.42.
- Adjusted EBITDA grew by 5% year-over-year to $142 million.
- Total debt was reduced by $198 million in the third quarter.
Headline financials
Revenue & EPS history
Owens & Minor · Revenue · Quarterly
$2.72B
Forward guidance
The company anticipates good sequential growth and cash flow from the third to fourth quarter, positioning them well for 2025. Each segment is expected to benefit from seasonality and recent investments as they finish 2024.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2024
+0.5%
Avg return
Earnings day
-0.2%
Avg return
5 days after
+2.3%
Avg return
30 days after
47%
32 / 68 earnings
Positive
+58.9%
Q2 2019
Best reaction
-37.6%
Q3 2018
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q1 2026 | +8.7% | -18.7% | -23.7% | |
| Q4 2025 | +5.7% | +4.8% | -21.0% | |
| Q3 2025 | -4.8% | -33.1% | -47.9% | |
| Q1 2025 | -9.6% | -6.8% | +3.2% | |
| Q4 2024 | +39.0% | +41.4% | +24.5% | |
| Q3 2024 | -11.7% | -3.4% | +10.3% | |
| Q2 2024 | -9.4% | -9.7% | -5.4% | |
| Q1 2024 | -21.6% | -26.1% | -28.9% | |
| Q4 2023 | +2.7% | +12.6% | +23.1% | |
| Q3 2023 | +25.0% | +19.1% | +39.5% | |
| Q2 2023 | +2.5% | +8.4% | -6.8% | |
| Q1 2023 | +31.2% | +35.7% | +57.4% | |
| Q4 2022 | -21.3% | -13.8% | -28.1% | |
| Q3 2022 | +3.9% | +9.2% | +19.8% | |
| Q2 2022 | -10.8% | -6.7% | -25.8% | |
| Q1 2022 | +10.3% | +4.7% | -5.2% | |
| Q4 2021 | +13.3% | +21.0% | +21.6% | |
| Q3 2021 | +23.8% | +18.3% | +9.5% | |
| Q2 2021 | -16.8% | -16.8% | -16.7% | |
| Q1 2021 | -4.0% | -4.7% | +19.8% | |
| Q4 2020 | +27.8% | +34.3% | +51.3% | |
| Q3 2020 | +1.3% | -2.5% | +0.2% | |
| Q2 2020 | -16.2% | -25.0% | -2.9% | |
| Q1 2020 | -6.3% | -2.9% | +5.6% | |
| Q4 2019 | -12.0% | -30.0% | +0.6% | |
| Q3 2019 | +8.1% | +5.9% | +16.9% | |
| Q2 2019 | +58.9% | +69.1% | +148.1% | |
| Q1 2019 | +7.4% | +7.4% | -27.1% | |
| Q4 2018 | -16.6% | -19.1% | -45.1% | |
| Q3 2018 | -37.6% | -33.9% | -46.3% | |
| Q2 2018 | -21.7% | -24.4% | -5.7% | |
| Q1 2018 | +6.8% | +9.4% | +8.2% | |
| Q4 2017 | +4.4% | +7.6% | +9.3% | |
| Q3 2017 | -24.0% | -21.2% | -23.7% | |
| Q2 2017 | -5.9% | -11.9% | -13.3% | |
| Q1 2017 | -4.8% | -5.4% | -6.3% | |
| Q4 2016 | -2.6% | -2.6% | -2.3% | |
| Q3 2016 | +1.0% | +0.6% | +5.4% | |
| Q2 2016 | -0.1% | -0.1% | -2.3% | |
| Q1 2016 | -2.2% | — | — | |
| Q4 2015 | +7.9% | — | — | |
| Q3 2015 | +1.1% | — | — | |
| Q2 2015 | +5.1% | — | — | |
| Q1 2015 | +3.8% | — | — | |
| Q4 2014 | -3.3% | — | — | |
| Q3 2014 | -2.1% | — | — | |
| Q2 2014 | -2.7% | — | — | |
| Q1 2014 | -2.4% | — | — | |
| Q4 2013 | +3.8% | — | — | |
| Q3 2013 | -1.5% | — | — | |
| Q2 2013 | -3.5% | — | — | |
| Q1 2013 | +6.9% | — | — | |
| Q4 2012 | -1.1% | — | — | |
| Q3 2012 | -1.0% | — | — | |
| Q2 2012 | -6.0% | — | — | |
| Q1 2012 | -2.5% | — | — | |
| Q4 2011 | -0.1% | — | — | |
| Q3 2011 | -1.5% | — | — | |
| Q2 2011 | +0.3% | — | — | |
| Q1 2010 | -0.2% | — | — | |
| Q1 2011 | +2.1% | — | — | |
| Q4 2008 | +2.5% | — | — | |
| Q4 2010 | +2.5% | — | — | |
| Q3 2009 | -1.4% | — | — | |
| Q3 2010 | -1.4% | — | — | |
| Q2 2010 | +2.4% | — | — | |
| Q2 2009 | +2.4% | — | — | |
| Q4 2009 | +2.4% | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro